Exelixis Inc – EXEL

Exelixis Inc, EXEL, founded in 1994 is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.

210 East Grand Avenue South
San Francisco, CA 94080
Phone: (650) 837-7000
Fax: (650) 837-8300

Healthcare | Biotechnology | USA

Exelixis EXEL
Exelixis EXEL
finviz dynamic chart for  EXEL

Dynavax Technologies Corporation – DVAX

Dynavax Technologies Corporation (DVAX) is a clinical-stage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer.

Stock Ticker: DVAX
Healthcare | Biotechnology

2929 Seventh Street, Suite 100
Berkeley, CA 94710
Phone: (510) 848.5100
Fax: (510) 848.1327

Website: http://www.dynavax.com/
DVAX SEC Filings

DVAX
DVAX
finviz dynamic chart for  DVAX